TP53 and colorectal carcinoma: In our screen for mutations in exons 5–8 of TP53 on genomic DNA from primary CRCs of 42 patients, we observed a mutation frequency of 45.2% (19 of 42), within the fairly wide range of values reported previously in CRC (23–61%) [29–34].